194

REFERENCES

1. Fauci AS, Kasper DL, Braunwald E, Hauser SL, Longo DL, Jameson JL,

Loscalzo J, editors. Harrrison’s Principles of Internal Medicine. 17th Edition.

New York. McGraw Hills; 2008. Available at: http://www.accessmedicine.co

2. Mohiuddin SF. The Diabetes Epidemic in India. [Jan 21, 2012] available at:

http://diabeteshealth.com/read/2012/01/21/7423/the-diabetes-epidemic-in-

india--/

3. King, Hilary. 1998. Conference proceedings. IX National Congress of

Diabetes, Mumbai.

4. Kokiwar PR, Gupta S, Durge PM. Prevalence of diabetes in a rural area of

central India. Int J Diab Dev Ctries. 2007;27(1):8-10.

5. care.diabetesjournals.org Standards of Medical Care in Diabetes- 2012.

Diabetes Care. 2012;35:S11-S63.

6. Kumar V, Abbas A K , Fausto N, editors. Robbins and Cotran Pathologic

Basis of Disease. 7th Edition. Pennsyl vania. Noordanesh Medical Publication

(Elsevier Saunders); 2005.

7. Brownlee M. Biochemistry and molecular cell biology of diabetic

complications. NATURE.2001;414:813-820.

8. Zelmanovitz T, Gerchman F, Balthazar A P S, Thomazelli F C S, Matos J D,

Canani L H. Diabetic nephropathy. Diabetology & Metabolic Syndrome.

2009;1:10 doi:10.1186/1758-5996-1-10.

9. Teoh SL, Latiff A ABD, Das S. Histological changes in the kidneys of

experimental diabetic rats fed with Momordica charantia (bitter gourd) extract.

Romanian Journal of Morphology and Embryology 2010;51(1):91–95.

10. Sima A A F, Nathaniel V, Bril V, Mcewen T A J Greene D A.

Histopathological Heterogeneity of Neuropathy in Insulin-dependent and Non

insulin-dependent Diabetes, and Demonstration of Axo-glial Dysjunction in

Human Diabetic Neuropathy J. Clin.Invest.1988;81:349-364.

11. Schalkwijk CG, Stehouwer C D A. Vascular complications in diabetes

mellitus: the role of endothelial dysfunction. Clinical Science. 2005;109:143–

159.

195

12. The Diabetes Control and Complications Trial Research Group. The effect of

intensive treatment of diabetes on the development and progression of long-

term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.

1993;329:977–986.

13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose

control with sulphonylureas or insulin compared with conventional treatment

and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet

1998;352:837–853.

14. McPhee SJ, Papadakis MA, Tierney LM, editors. CURRENT Medical

Diagnosis & Treatment. Mc Graw Hill, LANGE; 2008.

15. Kar A, Choudhary BK, Bandyopadhyay NG. Comparative evaluation of

hypoglycemic activity of some Indian medicinal plants in alloxan diabetic rats.

J Ethnopharmacol.2003; 84(1):105-108.

16. Mukherjee P K, Maiti K, Mukherjee K, Houghton P J. Leads from Indian

medicinal plants with hypoglycemic potentials. J. Ethnopharmacol.

2006;106(1):1-28.

17. Chattopadhyay RR. A comparative evaluation of some blood sugar lowering

agents of plant origin. J Ethnopharmacol.1999;67:367-372.

18. Tripathi A K., Bhoyar P K, Baheti J R, Biyani D M, Khalique M, Kothmire M

S, Amgaonkar Y M, Bhanarkar A B. Herbal Antidiabetics: A Review. Int. J.

Res. Pharm. Sci. 2011;2(1):30-37.

19. Birdee G S, Yeh G. Complementary and Alternative Medicine Therapies for

Diabetes: A Clinical Review. Clinical Diabetes. 2010;28(4):147-155.

20. Shojaii A, Goushegir A, Dabaghian F H, Abdollahi M, Huseini H F. Herbs

and herbal preparations for glycemic control in diabetes mellitus (a systematic

review). Journal of Medicinal Plants Research. 2011; 5(16):3846-3855.

Available online at http://www.academicjournals.org/JMPR

21. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam T P A. Indian Herbs

and Herbal Drugs Used for the Treatment of Diabetes. J. Clin. Biochem. Nutr.

2007;40:163–173.

22. Alarcon-Aguilar F J, Roman-Ramos R, Flores-Saenz J L, Aguirre-Garci F.

Investigation on the hypoglycemic effects of four Mexican medicinal plants

in normal and alloxan diabetic mice. Phytother Res. 2002;16(4):383-386.

196

23. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants.

Council of Scientific and Industrial Research. New Delhi.1956.

24. Kumar B D, Mitra A, Manjunatha M. In vitro and in vivo studies of

antidiabetic Indian medicinal plants: A Review. Journal of Herbal Medicine

and Toxicology. 2009;3(2):9-14.

25. Kamble SM, Kamlakar PL,Vaidya S,Bambole VD. Influence of Coccinia indica

on certain enzymes in glycolytic and lipolytic pathway in human diabetics. Ind J

Med Sci.1998;54(4):143-6.

26. Eldin I M T, Ahmed E M, Abd Elwahab H.M. Preliminary study of the

clinical Hypoglycemic effects of Allium cepa (Red Onion) in Type 1 and Type

2 Diabetic patients. Environmental Health Insights 2010;4 :71–77.

27. Leatherdale BA, Panesar RK, Singh G, Afkina TW, Bailley CJ, Bignell AH.

Improvement in glucose tolerance due to Momordica Charantia (Karela). Brit

Med J. (clinical research edition)1981;282(6279):1823-1824.

28. Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood

glucose and serum lipids in Type 1 diabetes. Eur J Clin Nutr 1990;44(4):301-

306.

29. Yoshikawa M, Nishida H, Takada M, KawharaY, Matsuda H. Polyphenol

constituents from Salacia species. Quantitative analysis of mangiferin with α –

glucosidase and aldose reductase inhibitory activities. Yakuguku Zasshi.

2001;121:371-378.

30. Lee H S. Rat lens aldose reductase inhibitory activities of Coptis japonica root

derived isoquinoline alkaloids. J Agri Food Chem. 2002;50(24):7013-7016.

31. Halder N, Joshi S, Gupta SK. Lens aldose reductase inhibitory potential of

some indigenous plants. J Ethnopharmacol. 2003;86:113-116.

32. Ortiz-Andrade RR, Garcia-Jimenez S, Castillo-Espana P, Ramirez-Avila G,

Vilalobos-Molina R, Estrada-Soto S. α- Glucosidase inhibitory activity of the

methanolic extract from Tournefotia hartwegiana: An anti-hyperglycemic

agent. J Ethnopharmacol. 2007;109(1):48-53.

33. Ivorra MD, Paya M, Villar A. Hypoglycemic and insulin release effect of

tormentic acid: a new hypoglycemic natural product. Planta Medica.

1988;54:282-286.

34. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents.

Phytomedicine. 1995;2(2):137-189.

197

35. Kar A, Choudhary BK, Bandyopadhyay NG. Preliminary studies on the

inorganic constituents of some hypoglycemic herbs on oral glucose tolerance

test. J Ethnopharmacol.1999;64(2):179-184.

36. Scartezzini P, Speroni E. Review on some plants of Indian traditional

medicine with antioxidant activity. J Ethnopharmacol. 2000;71: 23–43.

Available online at: www.elsevier.com:locate:jethpharm

37. Masuda T, Toi Y, Bando H, Mackawa T, Takeda Y, Yamaguchi H. Structural

identification of new curcumin dimmers and their contribution to the

antioxidant mechanism of curcumin. J Agri Food Chem. 2002;50(9):2524-

2530.

38. Leu TH, Maa MC. The molecular mechanisms for the antitumorigenic effect

of curcumin. Curr Med Chem Anti-Canc.Agents.2002;2:357-370.

39. Atangwho IJ, Ebong PE, Eyong EU, Williams IO, Eteng MU, Egbung GE.

Comparative chemical composition of leaves of some antidiabetic medicinal

plants: Azadirachta indica, Vernonia amygdalina and Gongronema latifolium.

African Journal of Biotechnology. 2009;8(18):4685-4689. Available online at

http://www.academicjournals.org/AJB

40. Dahanukar SA, Kulkarni RA, Rege NN. Pharmacology of medicinal plants

and natural products. Indian Journal of Pharmacology 2000;32:S81-S118.

41. Saneja A, Sharma C, Aneja K R, Pahwa R. Gymnema Sylvestre (Gurmar): A

Review. Der Pharmacia Lettre 2010;2(1):275-284.

42. WarreN RP, WarreN RM, Weninger MG. Inhibition of the Sweet Taste

by Gymnema sylvestre. Nature.1969;223:94 –95.

43. Gent J F, Hettinger T P, Frank M E, Marks L E. Taste confusions following

Gymnemic Acid Rinse. Chem Senses. 1999;24: 393-403.

44. Shore LE. A contribution to our knowledge of taste sensations. From the

Physiological Laboratory, Cambridge.191-217.

45. Shanmugasundaram ER, Gopinath KL, Shanmugasundaram KR, Rajendran V

M. Possible regeneration of the islets of langerhans in streptozotocin-diabetic

rats given Gymnema sylvestre leaf extracts. J

Ethnopharmacol.1990;30(3):265-279.

198

46. Shanmugasundaram E R B, Rajeswar G, Baskaran K, Kumar B R R,

Shanmugasundaram K R, Ahmath B K.Use of gymnema sylvestre leaf extract

in the control of blood glucose in insulin-dependent diabetes mellitus. J

Ethnopharmacol.1990;30:281- 294.

47. Okabayashi Y, Tani S, Fujisawa T, Koide M, Hasegawa H, Nakamura T,

Fujii M, Otsuki M. Effect of Gymnema sylvestre, R.Br. on glucose

homeostasis in rats. Diabetes Res Clin Pract. 1990;9(2):143-148.

48. Baskaran K, Kizar Ahmath B, Radha Shanmugasundaram K,

Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema

sylvestre in non-insulin-dependent diabetes mellitus patients. J

Ethnopharmacol. 1990;30:295-305.

49. Persaud SJ, Al-Majed H, Raman A, Jones PM. Gymnema sylvestre stimulates

insulin release in vitro by increased membrane permeability. J

Endocrinol.1999;163(2):207-212.

50. Kamei K, Takano R, Miyasaka A, Imoto T, Hara S. Amino acid sequence of

sweet-taste-suppressing peptide (gurmarin) from the leaves of Gymnema

sylvestre. J Biochem. 1992;111:109-12.

51. Liu H M, Kiuchi F, Tsuda Y. Isolation and structural elucidation of

Gymnemic acids, antisweet principles of Gymnema sylvestre. Chem. Pharm.

Bull. 1992;40(6):1366-1375.

52. Yoshikawa M, Murakami T, Kadoya M, Li Y, Murakami N, Yamahara J,

Matsuda H. Medicinal Foodstuffs. IX.1) The Inhibitors of Glucose Absorption

from the Leaves of Gymnema sylvestre R.BR. (Asclepiadaceae): Structure of

Gymnemosides a and b. Chem.Pharm.Bull.1997;45(10):1671-1676.

53. Yoshikawa M, Murakami T, Matsuda H. Medicinal Foodstuffs. X.1) Structure

of New Triterpene Glycosides, Gymnemosides-c,-d, -e, and –f, from the

Leaves of Gymnema sylvestre R. Br.: Influence of Gymnema Glycosides on

Glucose Uptake in Rat Small Intestinal Fragments.

Chem.Pharm.Bull.1997;45(12):2034-2038.

54. Chowdhary F, Rasool M H. Isolation and characterization of Gymnemic acid

from Indigenous Gymnema sylvestre. J App Pharm.2010;3(2):60-65.

55. Shanmugasundaram KR, Pannerselvam C, Samudram P, Shanmugasundaram

ER. Enzyme changes and glucose utilization in diabetic rabbits: the effect of

Gymnema sylvestre, R.Br. J Ethnopharmacol.1983;7(2):205-234.

199

56. Prakash AO, Mathur S, Mathur R. Effect of feeding gymnema sylvestre leaves

on blood glucose in beryllium nitrate treated rats.

J.Ethnopharmacol.1986;18:143-146.

57. Srivatsava Y, Bhatt H V, Jhala CI .Oral Gymnema sylvestre R.Br. leaf

extracts inducing protracted longevity and hypoglycemia in alloxan diabetic

rats: Review and experimental study. Int J Crude Drug Res.1986;24:171-176.

58. Shanmugasundaram ERB, Venkatasubrahmanyam M, Vijendran N,

Shanmugasundaram K R. Effect of isolate from Gymnema sylvestre R.Br. in

the control of diabetes mellitus and the associated pathological changes.

Ancient Science of Life. 1988;7:183-194.

59. Shimizu K, Iino A, Nakajima J, Tanaka K, Nakajyo S, Urakawa N, Atsuchi M,

Wada T, Yamashita C. Suppression of glucose absorption by some fractions

extracted by Gymnema sylvestre leaves. J Vet Med Sci. 1997;59(4):245-251.

60. Chattopadhyay RR. Possible mechanism of antihyperglycemic effect of

Gymnema sylvestre leaf extract, part I. Gen.Pharmacol.1998;31:495-496.

61. Galletto R, Siqueira V L D, Ferreira E B, Oliveira A J B, Bazotte R B.

Absence of Antidiabetic and Hypolipidemic Effect of Gymnema sylvestre in

Non-diabetic and Alloxan-Diabetic Rats. Brazilian Archives of Biology and

Technology. 2004;47(4):545-551.

62. Gholap S, Kar A. Gymnemic acids from Gymnema sylvestre. Potentially

regulates dexamethasone-induced hyperglycemia in mice. Pharmaceutical

Biology.2005;43:192-195.

63. Sujin R M, Subin R M, Mahesh R, Mary R V J. Anti-Diabetic Effect of

Gymnema sylvestre (Asclepiadaceae) Powder in the Stomach of Rats.

Ethnobotanical Leaflets 2008;12:1158-1167.

64. Liu B, Asare-Anane H, Al-Romaiyan A, Huang G C, Amiel S A, Jones P M,

Persaud S J. Characterization of the insulinotropic activity of an aqueous

extract of Gymnema sylvestre in mouse β –cells and human islets of

langerhans. Cell.Physiol.Biochem.2009;23:125-132.

65. Mall G K, Mishra P K , Prakash V. Antidiabetic and Hypolipidemic Activity

of Gymnema sylvestre in Alloxan Induced Diabetic Rats. Global Journal of

Biotechnology & Biochemistry 2009;4(1):37-42.

200

66. Bishayee A, Chatterjee M. Hypolipidaemic and antiatherosclerotic effects of

oral Gymnema sylvestre R.Br. leaf extract in albino rats fed on a high fat diet.

Phytotherapy Research. 1994;8(2):118-120.

67. Nakamura Y, Tsumura Y, Tonogai Y, Shibata T. Fecal steroid excretion is

increased in rats by oral administration of Gymnemic acids contained in

Gymnema sylvestre leaves. J. Nutrition. 1999;129:1214-1222.

68. Shigematsu N, Asano R, Shimosaka M, Okazaki M. Effect of Administration

with the Extract of Gymnema sylvestre R.Br Leaves on Lipid Metabolism in

Rats. Biol.Pharm.Bull. 2001;24(6):713-717.

69. Shigematsu N, Asano R, Shimosaka M, Okazaki M. Effect of Long Term-

Administration with Gymnema sylvestre R.Br on Plasma and Liver Lipid in

Rats. Biol.Pharm.Bull. 2001;24(6):643-649.

70. Preuss HG, Bagchi D, Bagchi M, Rao C V S, Dey D K., Satyanarayana S.

Effects of a natural extract of (–)-hydroxycitric acid (HCA-SX) and a

combination of HCA-SX plus niacin-bound chromium and Gymnema

sylvestre extract on weight loss. Diabetes, Obesity and Metabolism,

2004;6:171–180.

71. Gloria YY, David ME, Ted JK, Russell SP. Systematic review of herbs and

dietary supplements for glycemic control in diabetes. Diabetes Care.

2003;26(4):1277-1294.

72. Matthew JL. Gymnema sylvestre for diabetes mellitus: A Systematic Review.

The J of Alternative and Complementary Medicine. 2007;13(9):977-983.

73. Kanetkar P, Singhal R, Kamat M. Gymnema sylvestre: A Memoir.

J.Clin.Biochem.Nutr.2007;41:77-81.

74. Ogawa Y, Sekita K, Umemura T, Saito M, Ono A, Kawasaki Y, Uchida O,

MatsushimaY, Inoue T, Kanno J. Gymnema sylvestre leaf extract: a 52-week

dietary toxicity study in Wistar rats. Shokuhin Eiseigaku Zasshi. 2004;45(1):8-

18.

75. Fushiki T, Kojima A, ImotoT, Inoue K, SugimotoE. An Extract of Gymnema

sylvestre Leaves and Purified Gymnemic Acid Inhibits Glucose-Stimulated

Gastric Inhibitory Peptide Secretion in Rats. J. Nutr. 1992;122:2367-2373.

201

76. Preuss H G, Jarrell S T, Scheckenbach R, Lieberman S, Anderson R A.

Comparative Effects of Chromium, Vanadium and Gymnema Sylvestre on

Sugar-Induced Blood Pressure Elevations in SHR. Journal of the American

College of Nutrition. 1998;17(2):116–123.

77. Katsukawa H, Imoto T, Ninomiya Y. Induction of Salivary gurmarin-binding

proteins in rats fed Gymnema-containing diets. Chem. Senses.1999;24:387-

392.

78. Harada S, Kasahara Y. Inhibitory effect of gurmarin on palatal taste responses

to amino acids in the rat. Am J Physiol Regulatory Integrative Comp Physiol.

2000;278(6):R1513-R1517.

79. Devi B P, Ramasubramaniaraja R. Pharmacognostical and Antimicrobial

screening of Gymnema sylvestre R.Br, and evaluation of Gurmar herbal tooth

paste and powder, composed of Gymnema sylvestre R.Br, extracts in dental

caries. International Journal of Pharma and Bio Sciences. 2010;1(3) :1-16.

80. Trivedi P D, Pundarikakshudu K, Shah K. A Validated Reverse Phase Liquid

Chromatographic Method for Quantification of Gymnemagenin in the

Gymnema Sylvestre R. Br. Leaf Samples, Extract and Market Formulation.

Int. J. Appl. Sci. Eng. 2011;9(1):25-31.

81. Augusti KT, Joseph P, Babu TD. Biologically active principles isolated from

Salacia oblonga Wall. Indian J Physiol Pharmacol 1995;39(4):415-417.

82. Ismail TS, Gopalakrishnan S, Begum VH, Elango V. Anti-inflammatory

activity of Salacia oblonga Wall. and Azima tetracantha Lam. J

Ethnopharmacol. 1997;56(2):145-152.

83. Krishnakumar K, Augusti KT, Vijayammal PL. Hypoglycemic and anti-

oxidant activity of Salacia oblonga Wall. extract in streptozotocin-induced

diabetic rats. Indian J Physiol Pharmacol.1999;43(4):510-514. (abstract)

84. Matsuda H, Murakami T, Yashiro K, Yamahara J, Yoshikawa M. Antidiabetic

principles of natural medicines. IV. Aldose reductase and alpha-glucosidase

inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of

a new friedelane-type triterpene, kotalagenin 16-acetate. Chem Pharm

Bull.1999;47(12):1725-1729.

85. Krishnakumar K, Augusti KT, Vijayammal PL. Anti-Peroxidative and

hypoglycemic activity of Salacia oblonga extract in diabetic rats.

Pharmaceutical Biology.2000;38(2):101-105.

202

86. Wolf BW, Weisbrode SE. Safety evaluation of an extract from Salacia

oblonga. Food Chem Toxicol. 2003;41(6):867-874.

87. Li Y, Peng G, Li Q, Wen S, Huang T H W, Roufogalis B D, Yamahara J.

Salacia oblonga improves cardiac fibrosis and inhibits postprandial

hyperglycemia in obese Zucker rats. Life Sci. 2004;75:1735-1746. Available

online at:www.sciencedirect.com

88. Collene AL, Hertzler SR, Williams JA, Wolf BW. Effects of a nutritional

supplement containing Salacia oblonga extract on postprandial glycemia,

insulinemia, and breath hydrogen responses in healthy adults. Nutrition.

2005;21:848-854.

89. Heacock PM, Hertzler SR, Williams JA, Wolf BW. Effects of a medical food

containing an herbal alpha-glucosidase inhibitor on postprandial glycemia and

insulinemia in healthy adults. J Am Diet Assoc.2005;105(8):65-71.

90. Huang T H, Yang Q, Harada M, Uberai J, Radford J, Li G Q, Yamahara J,

Roufogalis B D, Li Y. Salacia oblonga root improves cardiac lipid metabolism

in zucker diabetic fatty rats: modulation of cardia PPAR-alpha-mediated

transcription of fatty acid metabolic genes. Toxicol Appl Pharmacol.

2006;210(1-2):78-85.

91. Huang TH, Peng G, Li G Q, Yamahara J, Roufogalis BD, Li Y. Salacia

oblonga root improves postprandial hyperlipidemia and hepatic steatosis in

Zucker diabetic fatty rats: Activation of PPAR-alpha. Toxicol Appl

Pharmacol. 2006;210(3):225-235.

92. Flammang AM, Erexson GL, Mecchi MS, Murli H. Genotoxicity testing of a

Salacia oblonga extract. Food Chem Toxicol. 2006;44(11):1868-1874.

93. Williams JA, Choe YS, Noss MJ, Baumgartner CJ, Mustad VA. Extract of

Salacia oblonga lowers acute glycemia in patients with type 2 diabetes. Am J

Clin Nutr.2007;86:124-130.

94. Hertzler S, Washam M,Williams J. Salacia oblonga extract reduces

postprandial glycemia following a solid, high-starch meal. The FASEB

Journal. 2007;21:832-839.

95. Huang TH, He L, Qin Q, Yang Q, Peng G, Harada M, Qi Y, Yamahara

J, Roufogalis B D, Li Y.Salacia oblonga root decreases cardiac hypertrophy in

Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II

type 1 receptor. Diabetes, Obesity and Metabolism.2008;10(7):574-585.

203

96. Rong X, Kim M S, Su N, Wen S, Matsuo Y, Yamahara J, Murray M, Li Y.

An aqueous extract of Salacia oblonga root, a herb-derived peroxisome

proliferator-activated receptor-alpha activator, by oral gavage over 28 days

induces gender-dependent hepatic hypertrophy in rats. Food Chem

Toxicol.2008;46(6):2165-2172.

97. Li Y, Huang TH, Yamahara J. Salacia root, a unique Ayurvedic medicine,

meets multiple targets in diabetes and obesity. Life Sci. 2008;82(21-22):1045-

1049.

98. He L, Qi Y, Rong X, Jiang J, Yang Q, Yamahara J, Murray M, Li Y. The

ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats:

suppression of angiotensin II/AT1 signaling. Evid Based Complement

Alternat Med. 2011, Article ID 807451, 12 pages.

99. Singh NK, Biswas A, Rabbani SI, Devi K, Khanam S. Hydroalcoholic root

bark extract of Salacia oblonga prevented mitomycin-C induced sperm

abnormality in wistar rats. Phcog Mag;2009;5(19):254-259.

100. Giron MD, Sevillano N, Salto R, Haidour A, Manzano M, Jimenez ML, Rueda

R, López-Pedrosa JM. Salacia oblonga extract increases glucose transporter 4-

mediated glucose uptake in L6 rat myotubes: role of mangiferin. Clinical

Nutrition 2009;28(5):565-574.

101. Donga JJ, Surani VS, Sailor GU, Chauhan SP, Seth AK. A Systematic

Review on Natural Medicine Used For Therapy of Diabetes Mellitus of Some

Indian Medicinal Plants. Pharma Science Monitor. An International Journal of

Pharmaceutical Sciences. 2011;2(1):36- 72.

102. Sahayam C S, Dubey GP, Rajamanickaam GV, Brindha P. Comparative study

of anti diabetic potential of Salacia species in Hippocrateaceae family. Journal

of Pharmacy Research. 2011;4(4):1113-1114. Available online through:

www.jpronline.info

103. Nakata K, Taniguchi Y, Yoshioka N, Yoshida A, Inagawa H, Nakamoto T,

Yoshimura H, Miyake S, Kohchi C, Kuroki M, Soma G I. A mixture of

Salacia oblonga extract and IP-PA1 reduces fasting plasma glucose (FPG) and

low-density lipoprotein (LDL) cholesterol levels. Nutrition Research and

Practice (Nutr Res Pract) 2011;5(5):435-442.

204

104. Kim M S, Huang T H W, Li G Q, Li Y, Roufogalis B D. Natural medicinal

products in diabetes research- Salacia oblon ga. Abstracts from the Third

International Congress on Complementary Medicine Research 2008. Abstract

No: 153. S-44.

105. Williams J A. A Novel Approach for Lowering Postprandial Glycemia.

www.AbbottNutritionHealthInstitute.org

106. Claus CR. Drugs producing diabetes through damage of the insulin

secreting cells. In : Pharmacological reviews. Williams and Wilkins

Company. 1970;22:508-517.

107. Srinivasan K., Ramarao P. Animal models in type 2 diabetes research: An

overview. Indian J Med Res. 2007;125:451-472.

108. Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, Burstow

D, Brown L.The streptozotocin-diabetic rat as a model of the chronic

complications of human diabetes. Heart Lung Circ.2003;12:44-50.

109. Weinberg ME, Bacchetti P, Rushakoff RJ. Frequently Repeated Glucose

Measurements Overestimate the Incidence of Inpatient Hypoglycemia and

Severe Hyperglycemia. J Diabetes Sci Technol 2010;4(3):577-582

110. Certificate of analysis. Product Name: Gymnema sylvestre extract. Batch

No:GS/08001. Quality control department, Natural Remedies Private

Limited, 5B, Veerasandra Indl.Area, Hosur Road, Bangalore-560100.

111. Certificate of analysis. Product Name: Salacia oblonga extract. Batch

No:GS/08001. Quality control department, Natural Remedies Private

Limited, 5B, Veerasandra Indl.Area, Hosur Road, Bangalore-560100.

112. Deshpande SS, Shah GB, Parmar NS. Antiulcer activity of Tephrosia

purpurea in rats. Indian Journal of Pharmacology. 2003;35:168-172.

113. Bidhe R M, Ghosh S. Acute and Subchronic (28-Day) Oral Toxicity Study

in Rats Fed with Novel Surfactants. AAPS PharmSci 2004;6 (2) Article 14

(http://www.aapspharmsci.org).

114. Selvan VT, Manikandan L, Kumar GPS, Suresh R, Kakoti BB, Gomathi P,

Kumar DA, Saha P, Gupta M, Mazumder UK. Antidiabetic and Antioxidant

Effect of Methanol Extract of Artanema sesamoides in Streptatozocin-

Induced Diabetic Rats. International Journal of Applied Research in Natural

Products. 2008;1(1):25-33.

205

115. Rathi SS, Grover JK, Vikrant V, Biswas NR. Prevention of experimental

diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res.

2002;16(8):774-777.

116. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis

and its enriched tannoids delay streptozotocin induced diabetic cataract in

rats. Molecular Vision 2007; 13:1291-7 Available at:

http://www.molvis.org/molvis/v13/a141/

117. Makino H, Tanaka I, Mukoyama M, Sugawara A, Mori K, Muro S,

Suganami T, Yahata K, Ishibashi R, Ohuchida S, Maruyama T, Narumiya S,

Nakao K. Prevention of Diabetic Nephropathy in Rats by Prostaglandin E

Receptor EP1-Selective Antagonist. J Am Soc Nephrol 2002; 13:1757–

1765.

118. Roche Diagnostics GmbH. D-68298 Mannheim, Germany. www.accu-

chek.com

119. Karl J. Development of Standardisation of a New Immunoturbidimetric

HbA1c Assay. Klin Lab 1993;39:991-996.

120. LINCO Research, 6 Research Park, Dr.St.Charles, Missouri 63304 USA.

121. Siedel J. AACC Meeting Abstract 34. Clin Chem 1993;39:1127.

122. Tietz NW. Clinical Guide to Laboratory Tests, 3rd ed. Philadelphia, Pa: WB

Saunders Company, 1995:130-131.

123. Sugiuchi H, Uji Y, Okabe H, Irie T. Direct Measurement of High-Density

Lipoprotein Cholesterol in Serum with Polyethylene Glycol-Modified

Enzymes and Sulfated -Cyclodextrin. Clin Chem 1995; 41 : 717-723.

124. Matsuzaki Y, Kawaguchi E, Morita Y. Evaluation of Two Kinds of

Reagents for Direct Determination of HDL-Cholesterol. J Anal Bio-Sc

1996;19:419-427.

125. Talke H, Schubert GE. Enzymatische Harnstoffbestimmung im Blut und

Serum im optischen Test nach Warburg. Klin Wschr 1965;43:174-175.

126. Foster-Swanson A, Swartzentruber M, Roberts P. Reference Interval Studies

of the Rate-Blanked Creatinine/Jaffe’ Method on BM/Hitachi Systems in Six

U.S. Laboratories. Clin Chem 1994; Abstact No. 361.

206

127. Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on

IFCC methods for the measurement of catalytic concentration of enzymes.

Part 2. IFCC Method for aspartate aminotransferase. J Clin Chem Clin

Biochem 1986;24:497-508.

128. Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on

IFCC methods for the measurement of catalytic concentration of enzymes.

Part 3. IFCC Method for alanine aminotransferase. J Clin Chem Clin

Biochem 1986;24:481-489.

129. Tietz NW, Rinker AD, Shaw LM. IFCC Methods for the Measurement of

Catalytic Concentration of Enzymes. Part 5. IFCC Method for Alkaline

Phosphatase. J. Clin. Chem. Clin. Biochem. 1983;21:731-748.

130. Klauke R, Schmidt E, Lorentz K. Recommendations for carrying out

standard ECCLS procedures (1988) for the catalytic concentrations of

creatine kinase, aspartate aminotransferase, alanine aminotransferase and γ-

glutamyltransferase at 37˚C. Eur J Clin Chem Clin Biochem 1993;31:907-

909.

131. Multi center study of Tina-quant Albumin in urine and β- N-acetyl-

glucosaminidase (β –NAG) in urine. Workshop Munich, November 29-30,

1990. Wien Klin Wschr.1991; 103, supplement189:1-64.

132. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement

with Folin Phenol Reagent. J Biol Chem 1951;193:265-275.

133. Tietz NW: Methods of determination of ascorbic acid. In : Text book of

clinical biochemistry. Nw Tietz, Ed, WB Saunders Company, Philedelphia

London, Toronto. 1986:960-962.

134. Butler. Estimation of Glutathione content of RBC and whole blood. J. Lab.

And Clin Med.1963;61:882.

135. Stocks J., Dormandy TL. The autooxidation of human red cell lipids. Br. J.

Haematol. 1971; 20:95-111.

136. Levine RL, Garland D, Oliver CN, Amiei A, Climent I, Lenz AG.

Determination of carbonyl content in oxidatively modified proteins. Meth.

Enzymol. 1990; 86:464-478.

137. Ellman GL. Measurement of protein thiols in plasma. Arch Biochem

Biophy. 1959 ; 82 : 70.

207

138. Lo S, Russell J C, Taylor A W. Determination of glycogen in small tissue

samples. J Appl Physiol. 1970;28(2):234-236.

139. Culling CFA. Handbook of Histopathological and Histochemical

Techniques (1974). Butterworth, London.

140. Sigma –Aldrich Corporation. 3050 Spruce St., St. Louis, Missouri 63103.

United States.

141. Ueda E, yoshikawa Y, Sakurai H, Kojima Y, Kajiwara N M. In Vitro

Alpha-glucosidase Inhibitory Effect of Zn(II) Complex with 6-Methyl- 2-

picolinmethylamide. Chem. Pharm. Bull.2005;53(4):451—452 .

142. Agappe Diagnostics Ltd. ‘Agappe Hills’, Dist Ernakulam, Kerala- 683562.

India.

143. Dagher Z, Park Y S, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M.

Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in

Human Diabetic Retinopathy. Diabetes. 2004; 53:2404–2411.

144. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the

polyol pathway in the early neuroretinal apoptosis and glial changes induced

by diabetes in the rat. Diabetes 2003;52(2):506 –511.

145. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI,

Kumagai AK, Frank RN, Stevens MJ. Aldose reductase inhibitor fidarestat

prevents retinal oxidative stress and vascular endothelial growth factor

overexpression in streptozotocin-diabetic rats. Diabetes 2003;52(3):864–

871.

146. Obrosova IG, Pacher P, Szabo C, Zsengeller Z, Hirooka H, Stevens MJ,

Yorek M A. Aldose reductase inhibition counteracts oxidative-nitrosative

stress and poly(ADP-ribose) polymerase activation in tissue sites for

diabetes complications. Diabetes 2005;54:234 –242.

147. Sun W, Oates P J, Coutcher J B, Gerhardinger C, Lorenzi M. A Selective

Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses

Early Retinal Abnormalities in Experimental Diabetic Retinopathy. Diabetes

2006;55(10):2757–2762.

148. Srivastava S K, Ramana KV, Bhatnagar A. Role of Aldose Reductase and

Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic

Options. Endocrine Reviews 2005;26(3):380–392.

208

149. Falcão M, Falcão-Reis F, Rocha-Sousa A. Diabetic Retinopathy:

Understanding Pathologic Angiogenesis and Exploring its Treatment

Options. The Open Circulation and Vascular Journal 2010;3:30-42.

150. Ciulla T A, Amador A G, Zinman B. Diabetic Retinopathy and Diabetic

Macular Edema. Pathophysiology, screening, and novel therapies. Diabetes

Care. 2003;26:2653–2664.

151. Kennedy A, Frank RN, Varma SD. Aldose reductase activity in retinal and

cerebral microvessels and cultured vascular cells. Invest Opthalmol &

Visual Sci 1983;24(9):1250–1258.

152. Yabe-NishimuraC. Aldose Reductase in Glucose Toxicity: A Potential

Target for the Prevention of Diabetic Complications. Invest Opthalmol &

Visual Sci 1998;50:21-33.

153. Mansou M A. Aldose Reductase in the Retina. Current Enzyme Inhibition.

2007;3(1):49-60.

154. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.

Prevention of retinal vessel changes associated with diabetic retinopathy in

galactose-fed dogs by aldose reductase inhibitors. Arch

Ophthalmol. 1990;108(9):1301-1309.

155. Robison WG Jr, Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabetic

like retinopathy in rats prevented with an aldose reductase inhibitor. Invest

Opthalmol & Visual Sci 1989;30(11):2285–2292.

156. Chakrabarti S, Sima A A. Effect of aldose reductase inhibition and insulin

treatment on retinal capillary basement membrane thickening in BB rats.

Diabetes 1989; 38(9):1181–1186. abstract

157. Suryanarayana P, Anilkumar P, Saraswat M, Petrash J M, Reddy G B.

Inhibition aldose reductase by tannoid principles of Emblica officinalis:

Implications for the prevention of sugar cataract. Molecular

Vision.2004;10:148-54. Available online at:

<http://www.molvis.org/molvis/v10/a20>

158. Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on

blood glucose, serum lipids & serum insulin in type 2 diabetes patients.

Indian J Med Res 2007;126:471-474.

159. Maritin AC, Sanders RA, Watkins JBIII. Diabetes, oxidative stress and anti

oxidants. J Biochem Molecular Toxicology. 2003;17(1):24-38.

209

160. Fagerberg SE. Diabetic neuropathy: a clinical and histologic study on the

significance of vascular affections. Acta Med Scand 1959;164:1–80.

161. Colciago A, Negri-Cesi P, Celotti F. Pathogenesis of diabetic neuropathy -

do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid

formation in the rat sciatic nerves? Exp Clin Endocrinol Diabetes

2002;110:22-26.

162. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and

sodium-potassium-ATPase in the pathogenesis of diabetic complications. N

Engl J Med 1987;316:599–606.

163. Nishimura C, Lou MF, Kinoshita JH. Depletion of myo-inositol and amino

acids in galactosemic neuropathy. J Neurochem 1987;49(1):290–295.

164. Chakrabarti S, Sima A A, Nakajima T, Yagihashi S, Greene D A. Aldose

reductase in the BB rat: isolation, immunological identification and

localization in the retina and peripheral nerve. Diabetologia 1987;30:244–

251.

165. Chakraborty U, Das H. Antidiabetic and Anti oxidant activities of

Cinnamomum tamala leaf extract in STZ-treated diabetic rats. Global J

Biotechnology and Biochemistry. 2010;5(1):12-18.

166. Shigeki E, Yoshihito O, Aysegül G, Ceyda Sibel E, Maskut CK., Toru O.

Inhibitory Effect of Traditional Turkish Folk Medicines on Aldose

Reductase (AR) and Hematological Activity, and on AR Inhibitory Activity

of Quercetin-3-O-methyl Ether Isolated from Cistus laurifolius L. Biol.

Pharm. Bull. 2004;27(7):1140—1143.

167. Hussain H E M A. Reversal of diabetic retinopathy in streptozotocin induced

diabetic rats using traditional Indian antidiabetic plant, Azadirachta indica

(L.). Ind J Clin Biochem 2002;17(2):115-123.

168. Anderson RS, Trune DR, Shearer TR. Histologic Changes in Selenite

Cortical Cataract. Investigative Ophthalmology & Visual Science

1988;29(9):1418-1427.

169. Sandberg HO , Closs O. The alpha and gamma crystalline content in

aqueous humor of eyes with clear lenses and with cataracts. Exp Eye Res

1979;28:601-610.

210

170. Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE, Trevithick JR.

Modelling cortical cataractogenesis: VII. Effects of butylated

hydroxytoluene (BHT) in reducing protein leakage from lenses in diabetic

rats. Exp Eye Res 1986;43(3):305-314.

171. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000;

49(2 Suppl 1):27-29.

172. Lapolla A, Traldi P, Fedel D. Importance of measuring products of non-

enzymatic glycation of proteins. Clinical Biochemistry.2005;38(2):103–115.

173. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early

glycation products: a mechanism for accelerated atherogenesis in diabetes.

Biochem Biophys Res Commun 1990; 173:932-938.

174. McLennan SV, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, Turtle JR.

Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991;

40(3):344-348.

175. Strain J J. Disturbances of micronutrient and antioxidant status in diabetes.

Proc Nutr Soc 1991; 50(3):591-604.

176. Baynes J W. Role of oxidative stress in development of complications in

diabetes. Diabetes 1991; 40:405-412.

177. Alderson NL, Chachich ME, Frizzell K, Canning P, Metz TO, Januszewski

A S, Youssef O, Stitt A, Baynes J, Thorpe S. Effect of antioxidants and

ACE inhibition on chemical modification of proteins and progression of

nephropathy in the streptozotocin diabetic rat. Diabetologia 2004;47:1385–

1395.

178. Tiwari A K, Rao J M. Diabetes mellitus and multiple therapeutic

approaches of phytochemicals: Present status and future prospects.

CURRENT SCIENCE. 2002; 83(1):30-38.

179. Packer L, Rfsen P, Tritschler HJ, King GL, Azzi A, 2000. Antioxidants in

Diabetes Management. Marcel Dekker, New York, pp. 1–338.

180. Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A,

Cao P, Sies H, Senin U. Plasma levels of lipophilic antioxidants in very old

patients with Type 2 diabetes Diab. Metab. Res. Rev. 2000;16(1):15–19.

181. Price K D, Price C S C, Reynolds R D. Hyperglycemia-induced ascorbic

acid deficiency promotes endothelial dysfunction and the development of

atherosclerosis. Atherosclerosis 2001;158(1): 1–12.

211

182. Valabhji J, Mc Coll AJ, Richmond W, Schachter M, Rubens MB, Elkeles

RS. Total Antioxidant Status and Coronary Artery Calcification in Type 1

Diabetes. Diabetes Care 2001;24(9):1608–1613.

183. Atanasiu RL, Stea D, Mateescu MA, Vergely C, Dalloz F, Briot F, Maupoil

V, Nadeau R, Rochette L. Direct evidence of ceruloplasmin antioxidant

properties. Mol Cell Biochem 1998; 189(1-2): 127–135.

184. Chatterjee IB, Nandi A. Ascorbic acid scavenges of oxyradicals. Indian J

Biochem Biophys 1991; 28: 233–236.

185. Infers H, Sies H. The protection by ascorbate and glutathione against

microsomal lipid peroxidation is dependent on vitamin E. Eur J Biochem

1988:74: 353–357.

186. Irshad M, Chaudhuri PS. Oxidant – antioxidant system; role and significance

in human body. Indian J Exp Biol 2002; 40(11): 1233–1239.

187. Sies H. Glutathione and its role in cellular functions. Free Radical Biology

and Medicine.1999;27(9–10) :916–921.

188. Madhu CG, Ojha S, Bansal DD. Antioxidant status of streptozotocin diabetic

rats. Indian J Exp Biol 1996;34(3): 264–266. abstract

189. Dewanjee S, Maiti A, Sahu R, Dua T K, Mandal V. Effective Control of

Type 2 Diabetes through Antioxidant Defense by Edible Fruits of Diospyros

peregrine. Evidence-Based Complementary and Alternative Medicine.

2011; Article ID 675397: 1- 7.

190. Awanti S M, Baruah P S, Prakash M. Serum and urine protein thiols in Type

2 diabetes mellitus patients. Indian J Physiol Pharmacol 2009; 53(2): 185-

188.

191. Yin P, Zhao S, Chen S, Liu J, Shi L, Wang X, Liu Y, Ma C. Hypoglycemic

and Hypolipidemic Effects of Polyphenols from Burs of Castanea

mollissima Blume. Molecules 2011;16: 9764-9774. Available at:

doi:10.3390/molecules16119764.

192. Shirwaikar A, Rajendran K, Kumar C D. Oral Antidiabetic Activity of

Annona squamosa Leaf Alcohol Extract in NIDDM Rats. Pharm boil. 2004;

42: 30-35.

193. Barreiro E, Gea J, Falco M D, Kriazhev L, James S, Hussain S N A. Protein

carbonyl formation in the diaphragm. Am J Respir Cell Mol Biol 2005;

32(1): 9-17.

212

194. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein

carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta

2003;329(1-2):23–38.

195. Zhang XF, Tan BKH. Antihyperglycemic and antioxidant properties of

Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol

Physiol 2000;27:358-363.

196. Soon YY, Tan BKH. Evaluation of the Hypoglycemic and Anti- Oxidant

Activities of Morinda officinalis in Streptozotocin-induced Diabetic Rats.

Singapore Med J 2002; 43(2): 077-085.

197. Sathishsekar D, Subramanian S. Antioxidant properties of Momordica

Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats. Asia

Pac J Clin Nutr 2005;14:153-158.

198. Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its

relationship with its antioxidant properties. Indian J Physiol Pharmacol

2004; 48(1): 81-88.

199. Raghavan B, Krishnakumari S. Effect of Terminalia arjuna stem bark on

antioxidant status in liver and kidney of alloxan diabetic rats. J Physiol

Pharmacol 2006; 50(2): 133-142.

200. Shibata S, Natori Y, NishiharaT, Tomisaka K, Matsumoto K, Sansawa H,

Nguyen V C. Antioxidant and anti cataract effects of Chlorella on rats with

STZ-induced diabetes. J Nutr Sci Vitaminol 2003;49:334-9.

201. Kasi R, Balasubramanian R, Sorimuthu S. Protective Effect of Eugenia

jambolana Seed Kernel on Tissue Antioxidants in Streptozotocin-Induced

Diabetic Rats. Biol. Pharm. Bull.2004;27:1212—1217.

202. Sarkar R, Hazra B, Biswas S, Mandai N. Evaluation of the in vitro

antioxidant and iron chelating activity of Gymnema sylvestre.

Pharmacologyonline 2009;3: 851-865.

203. Rachh PR, Patel SR, Hirpara HV, Rupareliya MT, Rachh MR, Bhargava AS,

Patel NM, Modi DC. In vitro evaluation of antioxidant activity of Gymnema

sylvestre R. Br. leaf extract. Rom. J. Biol. – Plant Biol.2009;54(2):141–148.

204. Fazal H, Ahmad N, Khan M A. Physico-chemical, phytochemical evaluation

and dpph-scavenging antioxidant potential in medicinal plants used for

herbal formulation in Pakistan . Pak. J. Bot. 2011; 43:63-67.

213

205. Zargar AH, Wandroo F A, Wadhwa MB, Laway BA, Masoodi SR, Shah

NA. Serum Lipid Profile in Non-insulin-dependent Diabetes Mellitus

Associated with Obesity Int. J. Diab. Dev. Countries 1995;15:9-13.

206. Miller CJ, Dunn EV, Hashim IB. Glycemic index of 3 varieties of dates.

Saudi Med. J. 2002;23(5):536-538.

207. Pari L, Latha M. Effect of Cassia Auriculata Flowers on Blood Sugar

Levels, Serum and Tissue Lipids in Streptozotocin Diabetic Rats. Singapore

Med J. 2002;43(12): 617-621.

208. Andallu B, Vinaykumar AV, Varadacharyulu NCh. Lipid abnormalities in

streptozotocin diabetes: Amelioration by Morus indica L. cv Suguna leaves.

Int J Diab Dev Ctries 2009; 29: 123-128.

209. Al-Jamal A, Alqadi T. Effects of Rosemary (Rosmarinus officinalis) on

Lipid Profile of Diabetic Rats. Jordan Journal of Biological

Sciences.2011;4(4):199–204.

210. Chait A, Brunzell JD, LeRoith D, Taylor SI, Olefsk JM. Diabetes, lipids, and

atherosclerosis. In: (Eds.), Diabetes Mellitus. Lippincott-Raven Publishers,

Philadelphia.1996 pp. 467–469.

211. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult

N Warnet JM, Claude JR, Rosselin GE.Hypertriglyceridaemia as a risk

factor of coronary heart disease mortality in subjects with impaired glucose

tolerance or diabetes. Diabetologia 1989;32,300–304.

212. Tanwy WHE, Hassanin LA. Hypoglycemic and hypolipidemic effects of

alcoholic extract of Tribulus alatus in streptozotocin –induced diabetic rats:

A comparative study with T.terrestris (Caltrop). Ind J Expt Biol

2007;45:785-790.

213. Pushparaj P, Tan CH, Tan BKH. Effects of Aerrhoa bilimbi leaf extract on

blood glucose and lipids in streptozotocin-diabetic rats. Journal of

Ethnopharmacology 2000; 72: 69–76.

214. Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic

effects and antioxidant activity of fruit extracts from Lycium barbarum. Life

Sciences 2004; 76: 137–149.

215. Vasudevan DM, Sreekumari S. Textbook of Biochemistry For Medical

Students (4th Ed). New Delhi, JAYPEE Brothers Medical Publishers (P) Ltd.

2005.

214

216. Sharma A, Mathur R, Shukla S. Hepatoprotective action of a proprietary

herbal preparation against carbon tetrachloride intoxication. Indian Drugs

1995;32:120-124.

217. Eder EE, Atangwho IJ, Akpanabiatu MI, Eder TE, Uboh FE, David-Oku E.

Effect of Gongronema latifolium leaf extract on some liver enzymes and

protein levels in diabetic and non diabetic rats. J Pharm Biomed Sci

2011;1:104-107.

218. Ilango K, Chitra V. Hepatoprotective and Antioxidant Activities of Fruit

pulp of Limonia acidissima Linn. International Journal of Health Research

2009; 2(4): 61-367. Available at http://www.ijhr.org

219. Mohamed Saleem TS, Christina AJM, Chidambaranathan N, Ravi V,

Gauthaman K. Hepatoprotective activity of Annona squamosa Linn. on

experimental animal model International Journal of Applied Research in

Natural Products 2008; 1(3): 1-7. Available online http://www.healthy-

synergies.com

220. Neuschwander-Tetri BA, Caldwell S H. Nonalcoholic steatohepatitis.

Summary of AASLD single topic conference. Hepatology 2003;37(5):1202-

1219.

221. Haris E H. Elevated liver function tests in type 2 diabetes. Clinical Diabetes

2005; 23(3):115-119.

222. Guven A, Yavuz O, Cam M, Ercan F, Bukan N, Comunoglu C, Gokce F.

Effects of melatonin on streptozotocin-induced diabetic liver injury in rats.

Acta histochemica 2006;108:85-93.

223. Saeed M K, Deng Y, Dai R. Attenuation of Biochemical Parameters in

Streptozotocin-induced Diabetic Rats by Oral Administration of Extracts

and Fractions of Cephalotaxus sinensis. J. Clin. Biochem. Nutr.

2008;42(1):21–28.

224. Nuhu AA, Aliyu R. Effects of Cassia occidentalis aqueous leaf extract on

biochemical markers of tissue damage in rats. Tropical Journal of

Pharmaceutical Research 2008;7: 1137-1142.

225. Ogbonnia S, Adekunle A A, Bosa M K, Enwuru V N. Evaluation of acute

and subacute toxicity of Alstonia congensis Engler (Apocynaceae) bark and

Xylopia aethiopica (Dunal) A. Rich (Annonaceae) fruits mixtures used in the

treatment of diabetes. African Journal of Biotechnology. 2008;7:701-705.

215

226. Udayakumar R Kasthurirengan S, Mariashibu T S, Rajesh M, Anbazhagan V

R Kim, S C, Ganapathi A, Choi C W. Hypoglycemic and hypolipidemic

effects of Withania somnifara root and leaf extracts on alloxan-induced

diabetic rats. Int J Mol Sci 2009;10:2367-2382. Available online at:

www.mdpi.com/journal/ijms

227. Jung C H, Zhou S, Ding G X, Kim J H, Hong M H, Shin Y C, Kim G J, Ko

S G. Antihyperglycemic activity of herb extracts on streptozotocin induced

diabetic rats. Biosci Biotechnol Biochem 2006; 70: 60238- 1-4.

228. Srividya A R, Varma S K, Dhanapal S P, Vadivelan R, Vijayan P.Invitro

and invivo evaluation of hepatoprotective activity of Gymnema sylvestre. Int

J Pharmaceutical Sci and Nanotechnology 2010; 2(4): 768-773.

229. Gray CH, Howorth PJN. Clinical chemical pathology. Edward Arnold

Publishers, 1980; 80-99.

230. Pimple BP, Kadam PV, Bafna NS, Patil MJ. Protective effect of Tamarindus

indica Linn. against paracetamol-induced hepatotoxicity in rats. Ind J

Pharmaceutical Sciences 2007;69:827-831.

231. Iweala E E J, Oludare F D. Hypoglycemic effect, biochemical and

histological changes of Spondias mombin Linn. and Parinari polyandra

Benth. seeds ethanolic extracts in alloxan-induced diabetic rats. J Pharmac

Toxicol 2011; 6(2):101-112.

232. Sambo N, Garba SH, Timothy H. Effect of the aqueous extract of Psidium

guajava on erythromycin-induced liver damage in rats. Niger J Physiol

Sci. 2009;24(2):171-6.

233. Singh N, Gupta M. Regeneration of β-cells in islets of langerhans of

pancreas of alloxan diabetic rats by acetone extract of Momordica charantia

(Linn.) (bitter gourd) fruits. Indian J Experimental Biology. 2007;45:1055-

1062

234. Nayak S B, Marshall J R, Isitor G, Adogwa A. Hypoglycemic and

Hepatoprotective Activity of Fermented Fruit Juice of Morinda citrifolia

(Noni) in Diabetic Rats Evidence-Based Complementary and Alternative

Medicine. 2011; Article ID 875293: 5 pages. Available at:

doi:10.1155/2011/875293.

216

235. Sunil C, Latha PG, Suja SR, Shine VJ, Shyamal S, Anuja GI, Sini S,

Rajasekharan S, Agastian P, Ignacimuthu S, Kalichelvan V. Effect of

Ethanolic Extract of Pisonia alba Span.Leaves on Blood Glucose levels and

Histological Changes in Tissues of Alloxan-Induced Diabetic rats.

International Journal of Applied Research in Natural Products. 2009;2(2):4-

11.

236. Jothivel N, Ponnusamy S P, Appachi M, Singaravel S, Rasilingam D,

Deivasigamani K, Thangavel S. Anti-diabetic activity of methanol leaf

extract of Costus pictus D.Don in alloxan-induced diabetic rats. J of Health

Science.2007;53(6):655-663.

237. Zal F, Vasei M, Rasti M, Vessal M. Hepatotoxicity associated with

hypoglycemic effects of Teucrium polium in diabetic rats. Arch Irn Med

200;4(4):188-192.

238. Arun K, Balasubramanian U. Comparative study on Hepatoprotective

activity of Aegle marmelos and Eclipta alba against alcohol induced in

albino rats. International Journal of Environmental Sciences.2011;2:389-

402.

239. Khalil EAM. Biochemical and histopathological studies on the influence of

aqueous extract of fenugreek seed (Trigonella foenum graecum) on alloxan

diabetic male rats. The Egyptian Journal of Hospital Medicine 2004;15 :83 –

94.

240. Jayanthi M, Sowbala N, Rajalakshmi G, Kanagavalli U, Sivakumar V. Study

of anti hyperglycemic effect of Catharanthus roseus in alloxan induced

diabetic rats. Int J Pharm Sci 2010;2(4):114-116.

241. Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J,

Alperovich G, Rama I, Vidal A, Grinyo JM. Mammalian Target of

Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney

Disease in Rats. J Am Soc Nephrol 17: 1395–1404, 2006. doi:

10.1681/ASN.2005050549

242. Remuzzi G, Benigni A, Remuzzi A. Mechanism of progression and

regression of renal lesions of chronic nephropathies and diabetes. J Clin

Invest. 2006;116(2):288–296. Available at: doi: 10.1172/JCI27699

217

243. Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS,

Remuzzi G, Benigni A. Effects of angiotensin II antagonism on the

regression of kidney disease in the rat. Kidney Int. 2002;62(3):885-894.

244. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E.

Reversal of glomerulosclerosis after high-dose enalapril treatment in

subtotally nephrectomised rats. J Am Soc Nephrol. 2003;14:2833-2842.

245. Mauer S M, Steffes M W, Ellis E N, Sutherland D E, Brown D M, Goetz

F C. Structural-Functional Relationships in Diabetic Nephropathy. J. Clin.

Invest. 1984;74(4):1143-1155.

246. Upadhya S, Shanbhag KK, Suneetha G, Balachandra Naidu M, Upadhya S.

A study of hypoglycemic and antioxidant activity of Aegle marmelos in

alloxan induced diabetic rats. Indian J Physiol Pharmacol 2004; 48(4):476-

480.

247. Mittal M, Juyal V, Singh A. Phytochemical, Antidiabetic, and

Cytoprotective Properties of Berberis aristata DC. Root Extracts.

Pharmaceutical Crops 2012; 3: 64-68.

248. Hussain H E M A. Hypoglycemic, hypolipidemic and antioxidant properties

of combination of curcumin from Curcuma longa, linn, and partially purified

product from Abroma augusta, linn. In streptozotocin induced diabetes

.Indian Journal of Clinical Biochemistry 2002; 17:33-43.

249. Shanmugam KR, Ramakrishna CH, Mallikarjuna K, Reddy K S. Protective

effect of ginger against alcohol- induced renal damage and anti oxidant

enzymes in male albino rats. Indian Journal of Experimental Biology

2010;48:143-149.

250. Marouane W, Soussi A, Murat JC, Bezzine S, Feki AEI. The protective

effect of Malva sylvestris on rat kidney damaged by vanadium. Lipids in

Health and Disease 2011, 10:65.

http://www.lipidworld.com/content/10/1/65.

251. Rosalina Tan RT, Mohamed S, Samaneh G F, Noordin MM, Goh YM,

Manap MYA. Polyphenol rich oil palm leaves extract reduce

hyperglycaemia and lipid oxidation in STZ-rats. International Food Research

Journal 2011;18: 179-188.

218

252. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML,

Zelmanovitz T. Diabetic Nephropathy: Diagnosis, Prevention, and

Treatment. Diabetes Care. 2005;28(1):164-176.

253. Anjaneyulu M, Chopra K. Quercetin an antioxidant bioflavanoid, attenuates

diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004;31: 244-248.

254. Berg TJ, Bangstad HJ, Torjesen PA, Osterby R, Bucala R, Hanseen KC.

Advanced glycation end products in serum predict changes in the kidney

morphology of patients with insulin-dependent diabetes mellitus.

Metabolism 1997; 46: 661-665.

255. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic

nephropathy. Kidney International. 2000;77:S3-S12.

256. Sadiq S, Nagi AH, Shahzad M, Zia A. The reno-protective effect of aqueous

extract of Carum carvi (Black zeera) seeds in streptozotocin induced diabetic

nephropathy in rodents. Saudi J Kidney Dis Transplant .2010;21(6):1058-

1065.

257. Mauer SM, Lane P, Hattori M, Fioretto P, Steffes MW. Renal structure and

function in insulin-dependent diabetes mellitus and type-I

membranoproliferative glomerulonephritis in human. J Am Soc Nephrol

1992; 2: S181-S184.

258. Chang WP, Dimitriadis E, AllenT, Dunlop ME, Cooper ME, Larkins RG.

The effect of aldose reductase inhibitors on glomerular prostaglandin

production and urinary albumin excretion in experimental diabetes.

Diabetologia. 1991;34:225-231.

259. Rasch R, Mogensen CE. Urinary excretion of albumin and total protein in

normal and streptozotocin diabetic rats. Acta Endocrinol (Copenh). 1980;

95: 376–381.

260. Grover JK, Yadav SP, Vats V. Effect of feeding Murraya koeingii and

Brassica juncea diet on kidney functions and glucose levels in streptozotocin

diabetic mice. J Ethnopharmacol. 2003;85:1–5.

261. Yadav UCS, Moorthy K, Baquer NZ. Combined treatment of sodium

orthovanadate and Momordica charantia fruit extract prevents alterations in

lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell

Biochem. 2005;268:111–120.

219

262. Grover JK, Vats V, Rathi SS, Dawar R. Traditional Indian anti-diabetic

plants attenuate progression of renal damage in streptozotocin induced

diabetic mice. J Ethnopharmacol. 2001;76:233–238.

263. Sun L, Halaihel N, Zhang W, Rogers T, Levi M. Role of sterol regulatory

element-binding protein 1 in regulation of renal lipid metabolism and

glomerulosclerosis in diabetes mellitus. J Biol Chem. 2002;277:18919–

18927.

264. Meyer C, Stumvoll M, Nadkami V, Dostou J, Mitrakou A, Gerich J.

Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.

J Clin Invest 1998;102:619–624.

265. Peterson DT, Greene WC, Reaven GM. Effect of experimental diabetes

mellitus on kidney ribosomal protein synthesis. Diabetes 1971; 20: 649–654.

266. Sunil C, Latha PG, Suja SR, Shine VJ, Shyamal S, Anuja GI et al. Effect of

Ethanolic Extract of Pisonia alba Span. Leaves on Blood Glucose levels and

Histological Changes in Tissues of Alloxan-Induced Diabetic rats.

International Journal of Applied Research in Natural Products. 2009;2:4-11.

267. Wang S, Lee S, Wang C, Lee C, Lee W, Lee H. Aqueous Extract from

Hibiscus sabdariffa Linnaeus Ameliorate Diabetic Nephropathy via

Regulating Oxidative Status and Akt/Bad/14-3-3γ in an Experimental

Animal Model. Evidence-Based Complementary and Alternative Medicine

2011; Article ID 938126: 9 pages.

268. El-Baky A E A, Amin H K. Effect of Citrullus colocynthis in ameliorate the

oxidative stress and nephropathy in diabetic experimental rats. International

Journal of Pharmaceutical Studies and Research.2011;2(2):1-10.

269. Baghian A, Lee KW. Role of activated macrophages in resistance to

systemic candidosis in beige mice.J med Vet Mycol . 1989;27: 51-55.

270. Raffel L, Pitsakis P, Levison SP, Levison ME. Experimental , and Candida

albicans, Staphylococcus aureus and Streptococcus faecalis pyelonephritis in

diabetic rats.Infect Immun 1981;34: 773-779.

271. Dangi KS, Mishra SN. Effect of Capparis aphylla stem extract treatment in

normal and streptozotocin induced diabetic rats infected with Candida

albicans. Asian J. Exp. Biol. Sci. 2011;2:102-107.

272. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells

of the rat pancreas. Physiological Research. 2001;50:536-546.

220

273. Bangar AV, Saralaya MG. Anti-hyperglycaemic activity of ethanol extract

and chloroform extract of Indigofera tinctoria leaves in streptozotocin

induced diabetic mice (Family- Papilionaceae). Research Journal of

Pharmaceutical, Biological and Chemical Sciences.2011;2(1):445-455.

274. Atangwho I J, Ebong P E, Egbung G E, Akpaso M I, Asuquo E E.

Histological Effect of Combined Extracts of Vernonia Amygdalina and

Azadirachta Indica on Normal and Diabetic Rats: the Pancreas and Liver.

Research Journal of Agriculture and Biological Sciences 2010;6(4):514-521.

275. Muthulingam M. Antidiabetic efficacy of leaf extracts of Asteracantha

longifolia (Linn.) Nees. on alloxan induced diabetics in male albino wistar

rats Int J Pharm Biomed Res 2010;1(2):28-34. Available online at:

www.pharmscidirect.com

276. Nagappa AN, Thakurdesai PA, Venkat Rao N, Jiwan Singh. Antidiabetic

activity of Terminalia catappa Linn fruits. J Ethnopharmacol 2003; 88: 45–

50.

277. Ahmed AB, Rao AS, Rao MV. In vitro callus and in vivo leaf extract

of Gymnema sylvestre stimulate β-cells regeneration and anti-diabetic

activity in Wistar rats. Phytomedicine 2010; 17(13):1033-1039.

278. Ahmed S M, Swamy BMV, Dhanapal P G R, Chandrashekara VM. Anti-

Diabetic Activity of Terminalia catappa Linn. Leaf Extracts in Alloxan-

Induced Diabetic Rats. Iranian J Pharmacology & Therapeutics 2005;4:36-

39.

279. Rajalakshmi M, Eliza J, Priya C E, Nirmala A, Daisy P. Anti-diabetic

properties of Tinospora cordifolia stem extracts on streptozotocin- induced

diabetic rats. African Journal of Pharmacy and Pharmacology. 2009;

3(5):171-180. Available online http://www.academicjournals.org/ajpp

280. Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of

Momordica charantia fruit juice on islet morphology in the pancreas of the

streptozotocin-diabetic rat Diabetes Research and Clinical

Practice.1998;40:145-151.

281. Adeyemi DO, Komolafe OA, Adewole OS, Obuotor EM, Abiodun AA,

Adenowo TK. Histomorphological and morphometric studies of the

pancreatic islet cells of diabetic rats treated with extracts of Annona

muricata. Folia Morphol. 2010;69:92-100.

221

282. Prince PSM, Srinivasan M. Enicostemma littorale Blume aqueous extract

improves the antioxidant status in alloxan-induced diabetic rat tissues. Acta

Poloniae Pharmaceutica n Drug Research. 2005;62(5):363-367.

283. Adewole S O, Caxton-Martins E A. Morphological Changes and

Hypoglycemic Effects of Annona Muricata Linn. (Annonaceae) Leaf

Aqueous Extract on Pancreatic Β-Cells of Streptozotocin-Treated Diabetic

Rats. African Journal of Biomedical Research. 2006;9:173 – 187.

284. Montanya E, Nacher V, Biarnés M, Soler J. Linear Correlation Between β-

Cell Mass and Body Weight Throughout the Lifespan in Lewis Rats Role of

β-Cell Hyperplasia and Hypertrophy. Diabetes. 2000;49(8):1341–1346.

285. Kaurich T. Drug-induced acute pancreatitis. Proc (Bayl Univ Med Cent)

2008;21:77–81.

286. Bahnak B R, Gold A H. Effects of Alloxan Diabetes on the Turnover of Rat

Liver Glycogen Synthase, comparison with liver phosphorylase. The Journal

of Biological chemistry. 1982;257(15):8775-8780.

287. Clore JN, Post EP, Bailey DJ, Nestler JE, Blackard WG. Evidence for

increased liver glycogen in patients with noninsulin-dependent diabetes

mellitus after a 3 day fast. J of Clinical endocrinology and Metabolism.

1992;74:660-666.

288. Ferrannini E, Lanfranchi A, Rohner. Jeanrenaud F, Manfredini G, Vande

Werve G. Influence of long-term diabetes on liver glycogen metabolism in

the rat. Metabolism 1990; 39(10):1082-1088. Abstract

289. Gavin N, Levinthal, Anthony S Tavill. Liver disease and diabetes mellitus.

Clinical Diabetes 1999; 17:73.

http://journal.diabetes.org/clinicaldiabetes/v17n21999/Pg73.htm

290. Maiti R, Jana D, Das UK, Ghosh D. Antidiabetic effect of aqueous extract of

seed of Tamarindus indica in streptozotocin –induced diabetic rats. J

Ethnopharmacol. 2004;92(1):85-91.

291. Shirwaikar A, Rajendran K, Barik R. Effect of aqueous bark extract of

Garuga pinnata Robx. in streptozotocin induced type-II diabetes mellitus. J

Ethnopharmacol. 2006;107(2):285-290.

292. Ogihara M, Tokumitsu Y, Ui M. Metabolic alterations in normal and

streptozotocin-diabetic rats in vivo: influence of prolonged starvation. Jpn J

Pharmacol 1984;34:307–311.

222

293. Adeghate E. Effect of subcutaneous pancreatic tissue transplants on

streptozotocin-induced diabetes in rats. II. Endocrine and metabolic

functions. Tissue Cell. 1999;3:73–83.

294. Stalmans W, De Wulf H, Hers HG. The control of liver glycogen synthetase

phosphatase by phosphorylase. Eur J Biochem 1971;18:582–587.

295. Stalmans W, De Wulf H, Hue L, Hers HG. The sequential inactivation of

glycogen phosphorylase and activation of glycogen synthetase in liver after

the administration of glucose to mice and rats. Eur J Biochem 1974;41:127–

134.

296. Stalmans W, Laloux M, Hers HG. The interaction of liver phosphorylase a

with glucose and AMP. Eur J Biochem 1974;49:415–427.

297. Massillon D, Bollen M, De Wulf H, Overloop K, Vanstapel F, Van Hecke P,

Stalmans W. Demonstration of a glycogen/ glucose 1-phosphate cycle in

hepatocytes from fasted rats. Selective inactivation of phosphorylase by 2-

deoxy-2-fluoro-a-Dglucopyranosyl fluoride. J Biol Chem

1995;270(33):19351–19356.

298. Cadefau J, Bollen M, Stalmans W. Glucose induced glycogenesis in liver

involves the glucose -6-phosphate dependent dephosphorylation of glycogen

synthase. Biochem J 1997;322:745– 750.

299. Nguyen HT, Kim SM. Three compounds with potent _-glucosidase

inhibitory activity purified from Sea Cucumber Stichopus japonicas.

SPISE2009;112-122.

300. Ali H, Houghton PJ, Soumyanath A. α-Amylase inhibitory activity of some

Malaysian plants used to treat diabetes; with particular reference to

Phyllanthus amarus. J Ethnopharmacol 2006;107:449–455.

301. Adisakwattana S, Pudhom K, Yibchok-anun S. Influence of the methanolic

extract from Abutilon indicum leaves in normal and streptozotocin-induced

diabetic rats. African Journal of Biotechnology 2009;8:2011-2015.

302. Yoshikawa M, Morikawa T, Matsuda H, Tanabe G, Muraoka O. Absolute

Stereostructure of Potent α-Glucosidase Inhibitor, Salacinol, with Unique

Thiosugar Sulfonium Sulfate Inner Salt Structure from Salacia reticulate.

Bioorganic & Medicinal Chemistry 2002;10(5):1547–1554.

223

303. Subramanian R, Asmawi MZ, Sadikun A. In vitro α-glucosidase and α-

amylase enzyme inhibitory effects of Andrographis paniculata extract and

andrographolide. Acta Biochimica Polonica. 2008;55(2):391–398.

304. Apostolidis E, Kwon YII, Shetty K. Potential of cranberry-based herbal

synergies for diabetes and hypertension management. Asia Pac J Clin Nutr

2006;15:433–441.

305. Anis E, Anis I, Ahmed S, Mustafa G, Malik A, Afza N, Hai SM, Shahzad-

ul-hussan S, Choudhary MI. α-Glucosidase inhibitory constituents from

Cuscuta reflexa. Chem Pharm Bull 2002;50(1):112–114.

306. Pullela SV, Tiwari AK, Vanka UMS, Vummenthula A, Tatipaka HB, Dasari

KR Khan IA, Janaswamy MR.HPLC assisted chemobiological

standardization of α-glucosidase-I enzyme inhibitory constituents from Piper

longum Linn-An Indian medicinal plant. J Ethnopharmacol.

2006;108(3):445–449.

307. Georgetti SR, Casagrande R, Vicentini FTMC, Verri WA, Fonseca MJV.

Evaluation of the antioxidant activity of soybean extract by different in vitro

methods and investigation of this activity after its incorporation in topical

formulations. Eur J Pharm Biopharm 2006;64: 99–106.

308. Ojieh G C, Oluba OM, Erifeta GO, Eidangbe GO. Effect of aqueous root

extract of Treculia africana on haemoglobin glycosylation and plasma lipid

peroxidation in streptozotocin-induced diabetic rabbits. International Journal

of Plant Physiology and Biochemistry. 2009;1:5-8.

http://www.academicjournals.org/IJPPB

309. Rajasekaran S, Sivagnanam K, Subramanian S. Antioxidant effect of Aloe

vera gel extract in streptozotocin-induced diabetes in rats. Pharmacologica

Reports.2005; 57(1): 90-96.

310. Tembhurne SV, Sakarkar D M. Protective effect of Murraya koenigii (L)

leaves extract in streptozotocin induced diabetics rats involving possible

antioxidant mechanism. Journal of Medicinal Plants Research.2010;4:2418-

2423. http://www.academicjournals.org/JMPR

311. Pandhare R B, Sangameswaran B, Mohite P B, Khanage S G. Aqueous

extracts of the leaves of Sesbania sesban reduces development of diabetic

nephropathy in streptozotocininduced diabetic rat Bangladesh J Pharmacol

2010; 5: 103-106.

224

312. Padee P, Nualkaew S, Talubmook C, Sakuljaitrong S. Hypoglycemic effect

of a leaf extract of Pseuderanthemum palatiferum (Nees) Radlk. in normal

and streptozotocin-induced diabetic rats. J Ethnopharmacol. 2010;132:491–

496.

313. Ramudu SK, Korivi M, Kesireddy N, Lee LC, Cheng IS, Kuo CH,

Kesireddy SR. Nephro-Protective Effects of a Ginger Extract on Cytosolic

and Mitochondrial Enzymes against Streptozotocin (STZ)-Induced Diabetic

Complications in Rats. Chinese Journal of Physiology 2011;54(2):79-86.

314. Yassin MM, Ashour ARA, Nehad R. Elyazji NR. Alterations in body

weight, protein profile, nonprotein nitrogen constituents and kidney structure

in diabetic rats under glibenclamide treatment. Journal of the Islamic

University of Gaza, (Natural Sciences Series) 2004; 12(1): 37-54.)

315. Alnahdi HS. Effect of Rosmarinus Officinalis Extract on some Cardiac

Enzymes of Streptozotocin-induced Diabetic Rats Journal of Health

Sciences 2012, 2(4): 33-37. DOI: 10.5923/j.health.20120204.03)

316. Divi S, Bellamkonda R, Dasireddy SK.. Evaluation of antidiabetic and

antihyperlipedemic potential of aqueous extract of Moringa oleifera in

fructose fed insulin resistant and STZ induced diabetic Wistar rats: A

comparative study. Asian Journal of Pharmaceutical and Clinical Research.

2012;5(1):67-72.)

317. Herbst K J, Coltharp C, Amzel L M, Zhang J. Direct Activation of Epac by

Sulfonylurea is Isoform Selective. Chem Biol. 2011;18(2):243–251.

318. Chackrewarthy S, Thabrew MI, Weerasuriya MKB, Jayasekera S.

Evaluation of the hypoglycemic and hypolipidemic effects o an ethylacetate

fraction ofArtocarpus heterophyllus (jak) leaves in streptozotocin-induced

diabetic rats. Pharmacognosy magazine.2010;6:186-190.

319. MacDonald PE, Wheeler MB. Voltage-dependent K+ channels in pancreatic

beta cells: Role, regulation and potential as therapeutic targets. Diabetologia

2003;46(8):1046–1062.

320. Hossain MS, Sokeng S, Shoeb M, Hasan K, Mosihuzzaman M, Nahar N, Ali

L,Rokeya B. Hypoglycemic effect of Irvingia gabonensis(Aubry-Lacomate

Ex. Ororke), Baill in Type 2 Diabetic Long-Evans Rats. Dhaka Univ. J.

Pharm. Sci. 2012;11(1):19-24.

225

321. Reddy SR, Lavany T, Narasimhulu G, ReddyKS. Effect of Pimpinella

tirupatiensis on Oxidative Enzymes in STZ-induced Diabetic Rat Kidney

Iranian Journal of Pharmaceutical Research. 2012;11(1): 277-286.